Axonics Inc (AXNX)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Raymond W. Cohen
Employees:
610
26 TECHNOLOGY DRIVE, IRVINE, CA 92618
949-396-6322

Axonics, Inc. engages in the development and commercialization of sacral neuromodulation (SNM) systems. SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinent.

Data derived from most recent annual or quarterly report
Market Cap 2.464 Billion Shares Outstanding49.964 Million Avg 30-day Volume 588.219 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.97
Price to Revenue8.9564 Debt to Equity0.0 EBITDA-45.736 Million
Price to Book Value4.5967 Operating Margin-18.848599999999998 Enterprise Value2.293 Billion
Current Ratio7.098 EPS Growth0.458 Quick Ratio6.004
1 Yr BETA 1.1031 52-week High/Low 79.92 / 46.57 Profit Margin-15.6381
Operating Cash Flow Growth137.4781 Altman Z-Score17.9329 Free Cash Flow to Firm -8.337 Million
Earnings Report2023-07-31
View SEC Filings from AXNX instead.

View recent insider trading info

Axonics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AXNX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AXNX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-31 by DEAREN DANNY L.
  • 4: filed on 2023-04-25 by DEAREN DANNY L.
  • 4: filed on 2023-04-24 by DEAREN DANNY L.
  • 4: filed on 2023-04-04 by DEAREN DANNY L.
  • 4: filed on 2022-09-20 by NOBLETT KAREN
  • 4: filed on 2022-09-15 by DEAREN DANNY L.
  • 4: filed on 2022-09-12 by WOOCK JOHN
  • 4: filed on 2022-09-09 by NOBLETT KAREN
  • 4: filed on 2022-08-26 by WOOCK JOHN
  • 4: filed on 2022-08-22 by LOPEZ ESTEBAN

    • Events (8k)

  • 8-K: filed on 2023-05-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-31:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-05:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-01:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-05:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-08:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

  • 144: filed on 2023-04-20:

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    30 Thousand total shares from 5 transactions

    Exercise Derivative Conversion (M)

    15.2 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DEAREN DANNY L. PRESIDENT & CFO

    • Officer
    		 9,202 2023-05-26 7

    SAMA RINDA CHIEF OPERATING OFFICER

    • Officer
    		 56,462 2023-02-21 4

    COHEN RAYMOND W CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 160,596 2023-01-31 4

    FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

    • Officer
    		 50,834 2023-01-31 2

    NOBLETT KAREN CHIEF MEDICAL OFFICER

    • Officer
    		 42,215 2023-01-31 3

    WOOCK JOHN EVP, CHIEF MKTG/STRTGY OFFICER

    • Officer
    		 65,302 2023-01-31 5

    LOPEZ ESTEBAN

    • Director
    		 3,600 2022-12-13 2

    CARREL MICHAEL H

    • Director
    		 15,361 2022-08-18 1

    KIERNAN JANE E

    • Director
    		 16,861 2022-08-18 1

    MCNAMARA ROBERT

    • Director
    		 11,861 2022-08-18 1

    DEMSKI DAVID M

    • Director
    		 6,542 2022-08-18 1

    SNYDERMAN NANCY LYNN MD

    • Director
    		 16,944 2022-08-18 1

    MCNAMARA ROBERT E

    • Director
    		 7,500 2021-01-13 0

    TAMMENOMS BAKKER JULIET

    • Director
    		 1,959,859 2020-09-18 0

    AMBLE ERIK

    • Director
    		 1,533,551 2020-08-24 0

    WISNIEWSKI RAPHAEL

    • Director
    • 10% Owner
    		 2,957,461 2020-01-17 0

    ANDERA PARTNERS

    BIODISCOVERY 4 FCPR

    • 10% Owner
    		 2,957,461 2020-01-17 0

    GILDE HEALTHCARE HOLDING B.V.

    GILDE HEALTHCARE IV MANAGEMENT B.V.

    COOPERATIEVE GILDE HEALTHCARE IV U.A.

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2019-11-21 0

    PARDO GEOFF

    • FORMER 10% OWNER
    		 No longer subject to file 2019-11-21 0

    WILLIAMSON MICHAEL V. SVP, GENERAL COUNSEL

    • Officer
    		 152,318 2019-07-01 0

    MATHUR PRABODH SEE REMARKS

    • Officer
    		 0 2019-01-30 0

    FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

    FORD ALFRED J JR CHIEF COMMERCIAL OFFICER

    • Officer
    		 0 2019-01-30 2

    JIANG GUANGQIANG CHIEF TECHNOLOGY OFFICER

    • Officer
    		 0 2019-01-30 0

    MALIK SHAHZAD

    • Director
    		 1,696,849 2018-12-06 0

    PETROVICH JOHN GEORGE

    • Director
    		 2,105,470 2018-12-06 0

    LONGITUDE CAPITAL PARTNERS III, LLC

    ENRIGHT PATRICK G

    LONGITUDE VENTURE PARTNERS III, L.P.

    • 10% Owner
    		 2,933,333 2018-11-02 0

    ADVENT LIFE SCIENCES LLP

    ADVENT LIFE SCIENCES FUND II LP

    • FORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2018-11-02 0

    NEOMED INNOVATION V LTD

    NEOMED INNOVATION V L.P.

    • FORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2018-11-02 0

    ALFRED E. MANN FOUNDATION FOR SCIENTIFIC RESEARCH

    • FORMER 10% OWNER
    		 No longer subject to file 2018-11-02 0

    KUANG ZHONG

    ZAC & CLOUD HOLDINGS LTD

    • FORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2018-11-02 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE GP, LLC

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    • Director
    • 10% Owner
    		 No longer subject to file 2018-10-31 0

    GILDE HEALTHCARE HOLDING B.V.

    GILDE HEALTHCARE IV MANAGEMENT B.V.

    • 10% Owner
    		 0 2018-10-30 0

    CORMORANT ASSET MANAGEMENT, LP

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND I, LP

    CHEN BIHUA

    • Director
    • 10% Owner
    		 0 2018-10-30 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-05-31 20:01:10 -0400 2023-05-26 S 300 $50.14 d 9,202 direct yes

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-05-31 20:01:10 -0400 2023-05-26 S 7,699 $49.44 d 9,502 direct yes

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-25 20:06:32 -0400 2023-04-21 S 9,637 $60.50 d 17,201 direct yes -1.3057 -9.8015 2.1065 4 -9.8015 6

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-25 20:06:32 -0400 2023-04-21 S 10,363 $59.93 d 26,838 direct yes -1.3057 -9.8015 2.1065 4 -9.8015 6

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-25 20:06:32 -0400 2023-04-21 M 13,208 $14.19 a 37,201 direct yes -1.3057 -9.8015 2.1065 4 -9.8015 6

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-25 20:06:32 -0400 2023-04-21 M 13,208 d 0 direct yes

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-24 20:35:19 -0400 2023-04-20 M 2,001 $14.19 a 25,994 direct yes -1.204 -9.2535 0.8772 5 -9.2535 6

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-24 20:35:19 -0400 2023-04-20 S 2,001 $60.01 d 23,993 direct yes -1.204 -9.2535 0.8772 5 -9.2535 6

    DEAREN DANNY L. - Officer PRESIDENT & CFO

    		2023-04-24 20:35:19 -0400 2023-04-20 M 2,001 d 13,208 direct yes

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AXONICS INC AXNX 2023-06-02 22:15:04 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 21:45:04 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 21:15:04 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 20:45:03 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 20:15:05 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 19:45:04 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 19:15:04 UTC 4.6519 0.4081 1700000
    AXONICS INC AXNX 2023-06-02 18:45:04 UTC 4.8057 0.2543 1700000
    AXONICS INC AXNX 2023-06-02 18:15:04 UTC 4.8057 0.2543 1700000
    AXONICS INC AXNX 2023-06-02 17:45:03 UTC 4.8057 0.2543 1700000
    AXONICS INC AXNX 2023-06-02 17:15:04 UTC 4.8057 0.2543 1700000
    AXONICS INC AXNX 2023-06-02 16:45:03 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 16:15:04 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 15:45:04 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 15:15:03 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 14:45:04 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 14:15:03 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 13:45:03 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 13:15:04 UTC 4.82 0.25 1700000
    AXONICS INC AXNX 2023-06-02 12:45:03 UTC 4.82 0.25 1600000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Index Plus All-Cap Fund AXNX -9.0 shares, $-228.69 2020-03-31 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Large-Cap Core Equity Plus Fund AXNX -1200.0 shares, $-76092.0 2021-06-30 N-PORT
    SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund AXNX -1506.0 shares, $-102332.7 2021-07-31 N-PORT
    Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund AXNX -1800.0 shares, $-117162.0 2021-09-30 N-PORT
    Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio AXNX -22000.0 shares, $-1431980.0 2021-09-30 N-PORT
    Trust for Professional Managers- Convergence Long/Short Equity Fund AXNX -921.0 shares, $-50111.61 2021-11-30 N-PORT
    NORTHERN LIGHTS FUND TRUST II- Invenomic Fund AXNX -186877.0 shares, $-11474247.8 2023-01-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments